LSE:AZN (AstraZeneca PLC)
About AZN
AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
AstraZeneca PLC (LSE: AZN) Latest News
Investing Articles
2022 dividend forecasts: HSBC, AstraZeneca, Glencore
Investing Articles
1 FTSE 100 stock I wouldn’t miss buying in November
Investing Articles
2 FTSE 100 dividend stocks I’d aim to never sell
Investing Articles
AstraZeneca (LON:AZN) makes progress in the fight against liver cancer
Investing Articles
These 2 FTSE 100 stocks are beaten down bargains in my opinion!
Investing Articles
Why I’d buy AstraZeneca shares today
Investing Articles
3 FTSE 100 stocks to buy for the long term
Investing Articles
2 UK shares to buy now for growth
Investing Articles
AstraZeneca (AZN) shares gain on acquisition news